Drug Lookup
Search FDA prescribing information by brand or generic name and get a clear, patient-ready summary of indications, dosing, side effects, and safety flags.
Matched label
Mounjaro
TIRZEPATIDE - Eli Lilly and Company
® is indicated as an adjunct to diet and exercise to improve glycemic control in adults and pediatric patients 10 years of age and older with type 2 diabetes mellitus. MOUNJARO ® is a glucose-dependent insulinotropic polypeptide (GIP) receptor and glucagon-like peptide-1 (GLP-1) receptor agonist indicated as an adjunct to diet and exercise to improve glycemic control in adults and pediatric patients 10 years of age and older with type 2 diabetes mellitus.
Label facts
- Application
- NDA215866
- Route
- SUBCUTANEOUS
- Label updated
- January 21, 2026
Indication
® is indicated as an adjunct to diet and exercise to improve glycemic control in adults and pediatric patients 10 years of age and older with type 2 diabetes mellitus. MOUNJARO ® is a glucose-dependent insulinotropic polypeptide (GIP) receptor and glucagon-like peptide-1 (GLP-1) receptor agonist indicated as an adjunct to diet and exercise to improve glycemic control in adults and pediatric patients 10 years of age and older with type 2 diabetes mellitus.
Dose and administration
The recommended starting dosage is 2. 5 mg injected subcutaneously once weekly. After 4 weeks, increase to 5 mg injected subcutaneously once weekly.
Side effects
- nausea
- diarrhea
- decreased appetite
- vomiting
- constipation
- dyspepsia
- abdominal pain
Safety flags
Acute Pancreatitis
Hypoglycemia with Concomitant Use of Insulin Secretagogues or Insulin
Hypersensitivity Reactions
Acute Kidney Injury Due to Volume Depletion
Severe Gastrointestinal Adverse Reactions
Retinopathy Complications in Patients with a History of Diabetic Retinopathy
Contraindication: A personal
Contraindication: family history of medullary thyroid carcinoma
Contraindication: in patients with Multiple Endocrine Neoplasia syndrome type 2
Source links
FDA-verified medication details are organized here so you can review the official label fast, then jump out to the original reference when you need the full text.
Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service. For informational use only. Verify against the full FDA label and clinical judgment.